Follow-up testing for tumorigenicity and oncogenicity
Closed Solicitation Posted
- Solicitation number
- 75D301-24-Q-78224
- Agency
- CDC Office of Acquisition Services Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Georgia 30341, United States
- Points of contact
-
- Dawnnia Daley xwf5@cdc.gov (404) 498-6079
- Liubov Kriel vyh1@cdc.gov (770) 488-2856
Notice details come from SAM.gov. Updated .
About this opportunity
Paragraph 1:
The Centers for Disease Control and Prevention (CDC) Office of Acquisition Services has issued a Request for Quote (RFQ) for the procurement of follow-up testing on the Master Cell Bank (MCB) of Expi293F cells to evaluate tumorigenicity and oncogenicity. This is a commercial item acquisition that will be awarded as a Firm-Fixed Price contract. The associated NAICS code is 621511 - Medical Laboratory Testing. Responses to the solicitation must be submitted by email to the Contract Specialist, Dawnnia Daley, no later than August 26, 2024. The solicitation incorporates standard FAR provisions and clauses, including instructions to offerors, evaluation criteria, and contract terms and conditions.
Paragraph 2:
This solicitation does not have a set-aside designation. No information is provided about potential incumbents or current contractors. The solicitation does not specify an award value or budget range. The quantity of testing services required is not stated, but the work is to be performed in Chamblee, GA. The period of performance for the contract is not explicitly defined.
Notice text
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
The solicitation number for this requirement is 75D301-24-Q-78224 and is hereby issued as a Request for Quote (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2024-05 dated May 22, 2024.
The associated North American Industrial Classification System (NAICS) code for this procurement 621511 —Medical Laboratory Testing.
This is a RFQ for the procurement of the test of Master Cell Bank (MCB) of Expi293F tm cells in further follow-up testing for tumorigenicity and oncogenicity. The Government intends to award a Firm-Fixed Price (FFP) contract as a result of this solicitation that will include the terms and conditions that are set forth herein.
The provision at 52.212-1, Instructions to Offerors-Commercial, applies to this acquisition along with the addenda to the provision included in the solicitation document. FAR 52.212-2, Evaluation-Commercial Items, is included, and the specific evaluation criteria are included in paragraph (a) of that provision.
Offerors shall include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications-Commercial Items, with its offer or indicate if it is available online at SAM.gov. FAR 52.212-4, Contract Terms and Conditions-Commercial Items, applies to this acquisition; there are no addenda to the clause. FAR 52.212-5, Contract Terms and Conditions Required To Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition and the additional FAR clauses cited in the clause that are applicable have been noted.
There are no additional contract requirement(s) or terms and conditions determined by the contracting officer to be necessary for this acquisition and consistent with customary commercial practices. No telephonic quotes will be processed. All responses must be received no later than the date stated above. Inquiries shall reference the solicitation number75D301-24-Q-78224, on the subject line and be sent to the Contract Specialist, Dawnnia Daley by email at xwf5@cdc.gov
Attachments
| File | Type | Posted |
|---|---|---|
| A19-Combined Synopsis 75D301-24-Q-78224.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Follow-up testing for tumorigenicity and oncogenicity | Solicitation | |
| Follow-up testing for tumorigenicity and oncogenicity | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity